drugset / Trial / NCT05395260
FL- 101 Study in Non-Metastatic MIBC
NaSingle-groupOpen-labelTreatment
Summary
A pilot window of opportunity study of FL-101 in patients with non-metastatic MIBC who are eligible for radical cystectomy (RC) but are ineligible for, or decline, cisplatin-based neoadjuvant therapy.
Timeline
- Start
- 2022-08-22
- Primary completion
- 2022-11-28
- Completion
- 2022-12-28
Outcome
Outcome not reported
Stopped (Business): “Sponsor Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FL-101 | Unknown | 200 mg | Intravenous |